Candidate superantigens were screened for their ability to induce lysis of human histocompatibility leukocyte antigen class II-positive targets by human CD8+ influenza-specific cytotoxic T cell (CTL) lines. Clostridium perfringens enterotoxin (CPET) induced major histocompatibility complex unrestricted killing by some but not all CTL lines. Using "anchored" polymerase chain reactions, CPET was shown to selectively stimulate peripheral blood lymphocytes bearing T cell receptor V beta 6.9 and V beta 22 in five healthy donors. V beta 24, V beta 21, V beta 18, V beta 5, and V beta 6.1-5 appeared to be weakly stimulated. Antigen processing was not required for CPET to induce proliferation. Like the staphylococcal enterotoxins, CPET is a major cause of food poisoning. These data suggest that superantigenic and enterotoxigenic properties may be closely linked.
Skip Nav Destination
Article navigation
1 September 1992
Article|
September 01 1992
Clostridium perfringens enterotoxin is a superantigen reactive with human T cell receptors V beta 6.9 and V beta 22.
P Bowness,
P Bowness
Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK.
Search for other works by this author on:
P A Moss,
P A Moss
Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK.
Search for other works by this author on:
H Tranter,
H Tranter
Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK.
Search for other works by this author on:
J I Bell,
J I Bell
Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK.
Search for other works by this author on:
A J McMichael
A J McMichael
Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK.
Search for other works by this author on:
P Bowness
,
P A Moss
,
H Tranter
,
J I Bell
,
A J McMichael
Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK.
Online ISSN: 1540-9538
Print ISSN: 0022-1007
J Exp Med (1992) 176 (3): 893–896.
Citation
P Bowness, P A Moss, H Tranter, J I Bell, A J McMichael; Clostridium perfringens enterotoxin is a superantigen reactive with human T cell receptors V beta 6.9 and V beta 22.. J Exp Med 1 September 1992; 176 (3): 893–896. doi: https://doi.org/10.1084/jem.176.3.893
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement